Home › NDC Lookup › RxCUI directory › RxCUI 1795944

Camphor 82.4 MG / Eucalyptus oil 16.5 MG / levomenthol 49.4 MG / peppermint oil 164.7 MG /... — RxCUI 1795944

Name: Camphor 82.4 MG / Eucalyptus oil 16.5 MG / levomenthol 49.4 MG / peppermint oil 164.7… (RxCUI 1795944)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1795944 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1795944

Official nameCamphor 82.4 MG / Eucalyptus oil 16.5 MG / levomenthol 49.4 MG / peppermint oil 164.7 MG / thymol 16.5 MG Medicated Patch

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Camphor 82.4 MG / Eucalyptus oil 16.5 MG / levom... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Camphor 82.4 MG / Eucalyptus oil 16.5 MG / levomenthol 49.4 MG / peppermint oil 164.7 MG / thymol 16.5 MG Medicated Patch RxCUI 1795944 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 6

The active substance itself — no strength, form, or brand attached yet.
- Camphor 1952 IN
- Eucalyptus oil 59087 IN
- Levomenthol 236388 IN
- Peppermint oil 33094 IN
- Thymol 10553 IN
- Camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol 1795943 MIN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol Medicated Patch 1795942 SCDF
- Camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol Topical Product 1795941 SCDG
- Medicated Patch 1792831 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Camphor 82.4 MG 1795936 SCDC
- Eucalyptus oil 16.5 MG 1795937 SCDC
- Levomenthol 49.4 MG 1795938 SCDC
- Peppermint oil 164.7 MG 1795939 SCDC
- Thymol 16.5 MG 1795940 SCDC

Showing up to 8 concepts per family — 15 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Camphor 82.4 MG SCDC · 1795936
Eucalyptus oil 16.5 MG SCDC · 1795937
Levomenthol 49.4 MG SCDC · 1795938
Peppermint oil 164.7 MG SCDC · 1795939
Thymol 16.5 MG SCDC · 1795940
Camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol Medicated Patch SCDF · 1795942
Camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol Topical Product SCDG · 1795941

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1795944 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55264-0012-05	1 POUCH in 1 CARTON (55264-012-05) / 5 PATCH in 1 POUCH (55...	SINSINPAP COOL	Sinsin Pharmaceutical Co., Ltd.	2016-05-30

Observed labelers: Sinsin Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.